The Gavi Leap tracker
Get the latest updates and view the progress made as part of global health's most ambitious reform programmes.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreFrom global reform to country leadership: delivering impact at the last mile
At last week's UN General Assembly a high-level dialogue co-hosted by Gavi, the Vaccine Alliance and the Government of Rwanda set out a pathway to stronger health systems and better health outcomes. Here are the key outcomes.
Meningitis in your words: Isabell Wachera's story
Confederation of Meningitis Organisations (CoMO) member Isabell shares her experience with TB meningitis.
Meningitis in your words: José Eduardo Oliva Marín’s story
José, a pediatric infectious disease specialist, shares how his work and personal life collided when his daughter Rebeca was diagnosed with meningitis.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allMade in Africa: New measles rapid diagnostic tests mark breakthrough for vaccination efforts
First-of-their-kind rapid measles diagnostic tests will support targeted vaccination during outbreaks and identification of priorities for preventive vaccination efforts.
New “blockbuster” tuberculosis vaccines could save seven million lives by 2050
Next-generation TB vaccines, expected to become available from 2029, could deliver major health and economic gains, helping to save an estimated 7.3 million lives, generate up to US$ 135 billion in economic benefits for low-and middle-income…
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
